Filing Details

Accession Number:
0001562180-21-005865
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-07 19:29:33
Reporting Period:
2021-09-02
Accepted Time:
2021-09-07 19:29:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1770121 Sana Biotechnology Inc. SANA Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1830070 Christian Hordo C/O Sana Biotechnology, Inc.
188 East Blaine Street, Suite 400
Seattle WA 98102
Evp, Chief Business Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-02 6,558 $1.48 977,356 No 4 M Direct
Common Stock Disposition 2021-09-02 6,558 $25.00 970,798 No 4 S Direct
Common Stock Disposition 2021-09-02 1,400 $25.00 969,398 No 4 S Direct
Common Stock Acquisiton 2021-09-03 700 $1.48 970,098 No 4 M Direct
Common Stock Disposition 2021-09-03 700 $25.00 969,398 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-09-02 6,558 $0.00 6,558 $1.48
Common Stock Stock Option (Right to Buy) Disposition 2021-09-03 700 $0.00 700 $1.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
128,708 2030-01-26 No 4 M Direct
128,008 2030-01-26 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.02, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.015, inclusive.
  4. This option began vesting on February 14, 2020, with 25% of the underlying shares becoming vested and exercisable on February 14, 2021 and the remainder of the underlying shares vesting at a rate of 1/36th per month thereafter.